{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:27:15Z","timestamp":1771331235170,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1007\/s10620-005-2472-5","type":"journal-article","created":{"date-parts":[[2005,3,23]],"date-time":"2005-03-23T13:42:13Z","timestamp":1111585333000},"page":"547-551","source":"Crossref","is-referenced-by-count":41,"title":["Impact of Immunosuppressive Treatment on Liver Fibrosis in Autoimmune Hepatitis"],"prefix":"10.1007","volume":"50","author":[{"given":"Mehdi","family":"Mohamadnejad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Malekzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siavosh","family":"Nasseri-Moghaddam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepideh","family":"Hagh-Azali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasser","family":"Rakhshani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohamad","family":"Tavangar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Sedaghat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Meysam","family":"Alimohamadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1053\/jhep.2000.19347","volume":"32","author":"T Poynard","year":"2000","unstructured":"Poynard T, McHutchison J, Davis GL, Esteban-Mur R, Goodman Z, Bedossa P, Albrecht J: Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. Hepatology 32:1131?1137, 2000","journal-title":"C. Hepatology"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJM200102083440604","volume":"344","author":"P Hammel","year":"2001","unstructured":"Hammel P, Couvelard A, O?Toole D, Ratouis A, Sauvanet A, Flejou JF, Degott C, Belghiti J, Bernades P, Valla D, Ruszniewski P, Levy P: Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 344:418?423, 2001","journal-title":"N Engl J Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jhep.2004.01.009","volume":"40","author":"AJ Czaja","year":"2004","unstructured":"Czaja AJ, Carpenter HA: Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J Hepatol 40:646?652, 2004","journal-title":"J Hepatol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"981","DOI":"10.7326\/0003-4819-127-11-199712010-00006","volume":"127","author":"JF Dufour","year":"1997","unstructured":"Dufour JF, DeLellis R, Kaplan MM: Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med 127:981?985, 1997","journal-title":"Ann Intern Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00004836-200105000-00014","volume":"32","author":"SJ Cotler","year":"2001","unstructured":"Cotler SJ, Jakate S, Jensen DM: Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy. J Clin Gastroenterol 32:428?430, 2001","journal-title":"J Clin Gastroenterol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1023\/A:1010683817344","volume":"46","author":"R Malekzadeh","year":"2001","unstructured":"Malekzadeh R, Nasseri-Moghaddam S, Kaviani MJ, Taheri H, Kamalian N, Sotoudeh M: Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis. Dig Dis Sci 46:1321?1327, 2001","journal-title":"Dig Dis Sci"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, Phillips MJ, Portmann BG, Poulsen H, Scheuer PJ, Schmid M, Thaler H: Histological grading and staging of chronic hepatitis. J Hepatol 22:696?699, 1995","journal-title":"J Hepatol"},{"key":"CR8","first-page":"518","volume":"38","author":"Wai CT","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS: A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38:518?526, 2003","journal-title":"Hepatology"},{"key":"CR9","first-page":"1462","volume-title":"Gastrointestinal and Liver Disease","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ: Autoimmune hepatitis. In Gastrointestinal and Liver Disease, 7th ed. Feldman M, Friedman LS, Sleizenger MH (eds). Philadelphia, Saunders, 2002, pp 1462?1473","edition":"7"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/ard.60.4.427","volume":"60","author":"A Marzano","year":"2001","unstructured":"Marzano A, Trapani A, Leone N, Actis GC, Rizzetto M: Treatment of idiopathic retroperitoneal fibrosis using cyclosporine A. Ann Rheum Dis 60:427?428, 2001","journal-title":"Ann Rheum Dis"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/rheumatology\/40.12.1431","volume":"40","author":"G Filaci","year":"2001","unstructured":"Filaci G, Cutolo M, Basso M, Murdaca G, Derchi L, Gianrossi R, Ropolo F, Zentilin P, Sulli A, Puppo F, Indiveri F: Long-term treatment of patients affected by systemic sclerosis with cyclosporin A. Rheumatology (Oxford) 40:1431?1432, 2001","journal-title":"Rheumatology (Oxford)"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0168-8278(03)00010-2","volume":"38","author":"WM Rosenberg","year":"2003","unstructured":"Rosenberg WM: Rating fibrosis progression in chronic liver diseases. J Hepatol 38: 357?360, 2003","journal-title":"J Hepatol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-2472-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-005-2472-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-2472-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:35:33Z","timestamp":1559244933000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-005-2472-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["2472"],"URL":"https:\/\/doi.org\/10.1007\/s10620-005-2472-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}